The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state (original) (raw)

• Kmieć, Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 161, III–XIII, 1–151 (2001).
  Google Scholar
• Brinkmann, A., Katz, N., Sasse, D. & Jungermann, K. Increase of the gluconeogenic and decrease of the glycolytic capacity of rat liver with a change of the metabolic zonation after partial hepatectomy. Hoppe Seylers Z. Physiol. Chem. 359, 1561–1571 (1978).
  CAS PubMed Google Scholar
• Schleicher, J., Dahmen, U., Guthke, R. & Schuster, S. Zonation of hepatic fat accumulation: insights from mathematical modelling of nutrient gradients and fatty acid uptake. J. R. Soc. Interface 14, 20170443 (2017).
  PubMed PubMed Central Google Scholar
• Hodson, L. & Frayn, K. N. Hepatic fatty acid partitioning. Curr. Opin. Lipidol. 22, 216–224 (2011).
  CAS PubMed Google Scholar
• Havel, R. J., Kane, J. P., Balasse, E. O., Segel, N. & Basso, L. V. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J. Clin. Invest. 49, 2017–2035 (1970).
  CAS PubMed PubMed Central Google Scholar
• Ontko, J. A. Metabolism of free fatty acids in isolated liver cells. Factors affecting the partition between esterification and oxidation. J. Biol. Chem. 247, 1788–1800 (1972).
  CAS PubMed Google Scholar
• Babin, P. J. & Gibbons, G. F. The evolution of plasma cholesterol: direct utility or a “spandrel” of hepatic lipid metabolism? Prog. Lipid Res. 48, 73–91 (2009).
  CAS PubMed Google Scholar
• Diraison, F. & Beylot, M. Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am. J. Physiol. 274, E321–E327 (1998).
  CAS PubMed Google Scholar
• Sidossis, L. S., Mittendorfer, B., Walser, E., Chinkes, D. & Wolfe, R. R. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am. J. Physiol. 275, E798–E805 (1998).
  CAS PubMed Google Scholar
• Adams, L. A., Sanderson, S., Lindor, K. D. & Angulo, P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol. 42, 132–138 (2005).
  PubMed Google Scholar
• Angulo, P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51, 373–375 (2010).
  PubMed PubMed Central Google Scholar
• Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865–873 (2006).
  CAS PubMed Google Scholar
• Bang, K. B. & Cho, Y. K. Comorbidities and metabolic derangement of NAFLD. J. Lifestyle Med. 5, 7–13 (2015).
  PubMed PubMed Central Google Scholar
• European Association for the Study of the Liver, European Association for the Study of Diabetes & European Association for the Study of Obesity. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388–1402 (2016).
  Google Scholar
• Romero-Gomez, M., Zelber-Sagi, S. & Trenell, M. Treatment of NAFLD with diet, physical activity and exercise. J. Hepatol. 67, 829–846 (2017).
  PubMed Google Scholar
• Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330–344 (2013).
  CAS PubMed Google Scholar
• Sahini, N. & Borlak, J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog. Lipid Res. 54, 86–112 (2014).
  CAS PubMed Google Scholar
• Severson, T. J., Besur, S. & Bonkovsky, H. L. Genetic factors that affect nonalcoholic fatty liver disease: a systematic clinical review. World J. Gastroenterol. 22, 6742–6756 (2016).
  CAS PubMed PubMed Central Google Scholar
• Piche, M. E., Parry, S. A., Karpe, F. & Hodson, L. Chylomicron-derived fatty acid spillover in adipose tissue: a signature of metabolic health? J. Clin. Endocrinol. Metab. 103, 25–34 (2018).
  PubMed Google Scholar
• Zechner, R. et al. FAT SIGNALS–lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 15, 279–291 (2012).
  CAS PubMed PubMed Central Google Scholar
• McQuaid, S. E. et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 60, 47–55 (2011).
  CAS PubMed Google Scholar
• Ruge, T. et al. Fasted to fed trafficking of fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. J. Clin. Endocrinol. Metab. 94, 1781–1788 (2009).
  CAS PubMed Google Scholar
• Hodson, L. et al. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state. Diabetes 56, 2433–2441 (2007).
  CAS PubMed Google Scholar
• Pramfalk, C. et al. Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults. Diabetes 65, 1858–1867 (2016).
  CAS PubMed Google Scholar
• Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343–1351 (2005).
  CAS PubMed PubMed Central Google Scholar
• Barrows, B. R. & Parks, E. J. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 91, 1446–1452 (2006).
  CAS PubMed Google Scholar
• Hodson, L. et al. Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation? Am. J. Physiol. Endocrinol. Metab. 299, E584–E592 (2010).
  CAS PubMed PubMed Central Google Scholar
• Vedala, A., Wang, W., Neese, R. A., Christiansen, M. P. & Hellerstein, M. K. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J. Lipid Res. 47, 2562–2574 (2006).
  CAS PubMed Google Scholar
• Nestel, P. J. Relationship between FFA flux and TGFA influx in plasma before and during the infusion of insulin. Metabolism 16, 1123–1132 (1967).
  CAS PubMed Google Scholar
• Holt, H. B. et al. Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 49, 141–148 (2006).
  CAS PubMed Google Scholar
• Karpe, F., Dickmann, J. R. & Frayn, K. N. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60, 2441–2449 (2011).
  CAS PubMed PubMed Central Google Scholar
• Langin, D. & Arner, P. Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol. Metab. 17, 314–320 (2006).
  CAS PubMed Google Scholar
• Stern, J. H., Rutkowski, J. M. & Scherer, P. E. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 23, 770–784 (2016).
  CAS PubMed PubMed Central Google Scholar
• Luukkonen, P. K. et al. Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars. Diabetes Care 41, 1732–1739 (2018).
  CAS PubMed PubMed Central Google Scholar
• Howe, H. R. 3rd et al. Increased adipose tissue lipolysis after a 2-week high-fat diet in sedentary overweight/obese men. Metabolism 60, 976–981 (2011).
  CAS PubMed Google Scholar
• Mashek, D. G. Hepatic fatty acid trafficking: multiple forks in the road. Adv. Nutr. 4, 697–710 (2013).
  CAS PubMed PubMed Central Google Scholar
• Immonen, H. et al. Increased liver fatty acid uptake is partly reversed and liver fat content normalized after bariatric surgery. Diabetes Care 41, 368–371 (2018).
  CAS PubMed Google Scholar
• Iozzo, P. et al. Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 139, 846–856 (2010).
  CAS PubMed Google Scholar
• Grundy, S. M. & Mok, H. Y. Chylomicron clearance in normal and hyperlipidemic man. Metabolism 25, 1225–1239 (1976).
  CAS PubMed Google Scholar
• Hultin, M., Savonen, R. & Olivecrona, T. Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling. J. Lipid Res. 37, 1022–1036 (1996).
  CAS PubMed Google Scholar
• Cooper, A. D. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38, 2173–2192 (1997).
  CAS PubMed Google Scholar
• Havel, R. J. & Hamilton, R. L. Hepatic catabolism of remnant lipoproteins: where the action is. Arterioscler. Thromb. Vasc. Biol. 24, 213–215 (2004).
  CAS PubMed Google Scholar
• Craig, W. Y. & Cooper, A. D. Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells. J. Lipid Res. 29, 299–308 (1988).
  CAS PubMed Google Scholar
• Wu, X., Sakata, N., Dixon, J. & Ginsberg, H. N. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms. J. Lipid Res. 35, 1200–1210 (1994).
  CAS PubMed Google Scholar
• Suppli, M. P. et al. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am. J. Physiol. Gastrointest. Liver Physiol. 316, G462–G472 (2019).
  CAS PubMed Google Scholar
• Mamo, J. C. et al. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am. J. Physiol. Endocrinol. Metab. 281, E626–E632 (2001).
  CAS PubMed Google Scholar
• Min, H. K. et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15, 665–674 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bieghs, V. et al. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLOS ONE 7, e30668 (2012).
  CAS PubMed PubMed Central Google Scholar
• Woollett, L. A., Spady, D. K. & Dietschy, J. M. Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J. Lipid Res. 33, 77–88 (1992).
  CAS PubMed Google Scholar
• Hazarika, A., Kalita, H., Kalita, M. C. & Devi, R. Withdrawal from high-carbohydrate, high-saturated-fat diet changes saturated fat distribution and improves hepatic low-density-lipoprotein receptor expression to ameliorate metabolic syndrome in rats. Nutrition 38, 95–101 (2017).
  CAS PubMed Google Scholar
• Sanders, F. W. & Griffin, J. L. De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol. Rev. Camb. Philos. Soc. 91, 452–468 (2016).
  PubMed Google Scholar
• Foster, D. W. Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J. Clin. Invest. 122, 1958–1959 (2012).
  CAS PubMed PubMed Central Google Scholar
• McGarry, J. D., Takabayashi, Y. & Foster, D. W. The role of malonyl-CoA in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J. Biol. Chem. 253, 8294–8300 (1978).
  CAS PubMed Google Scholar
• Raichur, S. et al. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 20, 687–695 (2014).
  CAS PubMed Google Scholar
• Xia, J. Y. et al. Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis. Cell Metab. 22, 266–278 (2015).
  CAS PubMed PubMed Central Google Scholar
• Law, B. A. et al. Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes. FASEB J. 32, 1403–1416 (2018).
  CAS PubMed PubMed Central Google Scholar
• Field, C. J., Ryan, E. A., Thomson, A. B. & Clandinin, M. T. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J. Biol. Chem. 265, 11143–11150 (1990).
  CAS PubMed Google Scholar
• Leamy, A. K. et al. Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J. Lipid Res. 55, 1478–1488 (2014).
  CAS PubMed PubMed Central Google Scholar
• Listenberger, L. L. et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl Acad. Sci. USA 100, 3077–3082 (2003).
  CAS PubMed Google Scholar
• Shimano, H. & Sato, R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat. Rev. Endocrinol. 13, 710–730 (2017).
  CAS PubMed Google Scholar
• Filhoulaud, G., Guilmeau, S., Dentin, R., Girard, J. & Postic, C. Novel insights into ChREBP regulation and function. Trends Endocrinol. Metab. 24, 257–268 (2013).
  CAS PubMed Google Scholar
• Repa, J. J. et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14, 2819–2830 (2000).
  CAS PubMed PubMed Central Google Scholar
• Linden, A. G. et al. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J. Lipid Res. 59, 475–487 (2018).
  CAS PubMed PubMed Central Google Scholar
• Chen, G., Liang, G., Ou, J., Goldstein, J. L. & Brown, M. S. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl Acad. Sci. USA 101, 11245–11250 (2004).
  CAS PubMed Google Scholar
• Lambert, J. E., Ramos-Roman, M. A., Browning, J. D. & Parks, E. J. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146, 726–735 (2014).
  CAS PubMed Google Scholar
• Diraison, F., Moulin, P. & Beylot, M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29, 478–485 (2003).
  CAS PubMed Google Scholar
• Lee, J. J. et al. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am. J. Clin. Nutr. 101, 34–43 (2015).
  CAS PubMed Google Scholar
• Marques-Lopes, I., Ansorena, D., Astiasaran, I., Forga, L. & Martinez, J. A. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men. Am. J. Clin. Nutr. 73, 253–261 (2001).
  CAS PubMed Google Scholar
• Schwarz, J. M., Linfoot, P., Dare, D. & Aghajanian, K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am. J. Clin. Nutr. 77, 43–50 (2003).
  CAS PubMed Google Scholar
• Higuchi, N. et al. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol. Res. 38, 1122–1129 (2008).
  CAS PubMed Google Scholar
• Kohjima, M. et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int. J. Mol. Med. 21, 507–511 (2008).
  CAS PubMed Google Scholar
• Lima-Cabello, E. et al. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin. Sci. 120, 239–250 (2011).
  CAS PubMed Google Scholar
• Hudgins, L. C. et al. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J. Lipid Res. 41, 595–604 (2000).
  CAS PubMed Google Scholar
• Wilke, M. S. et al. Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia 52, 1628–1637 (2009).
  CAS PubMed Google Scholar
• Janevski, M. et al. Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat. Food Funct. 3, 141–149 (2012).
  CAS PubMed Google Scholar
• Chong, M. F., Fielding, B. A. & Frayn, K. N. Mechanisms for the acute effect of fructose on postprandial lipemia. Am. J. Clin. Nutr. 85, 1511–1520 (2007).
  CAS PubMed Google Scholar
• Sun, S. Z. & Empie, M. W. Fructose metabolism in humans - what isotopic tracer studies tell us. Nutr. Metab. 9, 89 (2012).
  Google Scholar
• Cox, C. L. et al. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur J. Clin. Nutr. 66, 201–208 (2012).
  CAS PubMed Google Scholar
• Jensen, T. et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J. Hepatol. 68, 1063–1075 (2018).
  CAS PubMed PubMed Central Google Scholar
• Moore, J. B., Gunn, P. J. & Fielding, B. A. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients 6, 5679–5703 (2014).
  CAS PubMed PubMed Central Google Scholar
• Le, K. A. et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am. J. Clin. Nutr. 89, 1760–1765 (2009).
  CAS PubMed Google Scholar
• Sobrecases, H. et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab. 36, 244–246 (2010).
  CAS PubMed Google Scholar
• Stanhope, K. L. et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119, 1322–1334 (2009).
  CAS PubMed PubMed Central Google Scholar
• Chiavaroli, L. et al. Effect of fructose on established lipid targets: a systematic review and meta-analysis of controlled feeding trials. J. Am. Heart Assoc. 4, e001700 (2015).
  PubMed PubMed Central Google Scholar
• Chiu, S. et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur. J. Clin. Nutr. 68, 416–423 (2014).
  CAS PubMed PubMed Central Google Scholar
• Chung, M. et al. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am. J. Clin. Nutr. 100, 833–849 (2014).
  CAS PubMed PubMed Central Google Scholar
• Asgari-Taee, F. et al. Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur. J. Nutr. 58, 1759–1769 (2019).
  CAS PubMed Google Scholar
• Wijarnpreecha, K., Thongprayoon, C., Edmonds, P. J. & Cheungpasitporn, W. Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis. QJM 109, 461–466 (2016).
  CAS PubMed Google Scholar
• Kanerva, N., Sandboge, S., Kaartinen, N. E., Mannisto, S. & Eriksson, J. G. Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am. J. Clin. Nutr. 100, 1133–1138 (2014).
  CAS PubMed Google Scholar
• Coleman, R. A. & Lee, D. P. Enzymes of triacylglycerol synthesis and their regulation. Prog. Lipid Res. 43, 134–176 (2004).
  CAS PubMed Google Scholar
• Nguyen, P. et al. Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. 92, 272–283 (2008).
  CAS Google Scholar
• Wang, H., Airola, M. V. & Reue, K. How lipid droplets “TAG” along: glycerolipid synthetic enzymes and lipid storage. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1862, 1131–1145 (2017).
  CAS PubMed Google Scholar
• Lewin, T. M. et al. Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition. Biochim. Biophys. Acta 1781, 352–358 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yen, C. L., Nelson, D. W. & Yen, M. I. Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism. J. Lipid Res. 56, 489–501 (2015).
  CAS PubMed PubMed Central Google Scholar
• Ohsaki, Y. et al. PML isoform II plays a critical role in nuclear lipid droplet formation. J. Cell Biol. 212, 29–38 (2016).
  CAS PubMed PubMed Central Google Scholar
• Brunt, E. M. Pathology of fatty liver disease. Mod Pathol. 20 (Suppl. 1), S40–S48 (2007).
  CAS PubMed Google Scholar
• Tandra, S. et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J. Hepatol. 55, 654–659 (2011).
  PubMed Google Scholar
• Yersiz, H. et al. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers. Liver Transpl. 19, 437–449 (2013).
  PubMed Google Scholar
• Fromenty, B., Berson, A. & Pessayre, D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J. Hepatol. 26 (Suppl. 1), 13–22 (1997).
  CAS PubMed Google Scholar
• Fromenty, B. & Pessayre, D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J. Hepatol. 26 (Suppl. 2), 43–53 (1997).
  CAS PubMed Google Scholar
• Takahashi, Y. & Fukusato, T. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 20, 15539–15548 (2014).
  PubMed PubMed Central Google Scholar
• Walther, T. C., Chung, J. & Farese, R. V. Jr Lipid droplet biogenesis. Annu. Rev. Cell Dev. Biol. 33, 491–510 (2017).
  CAS PubMed PubMed Central Google Scholar
• Mashek, D. G., Khan, S. A., Sathyanarayan, A., Ploeger, J. M. & Franklin, M. P. Hepatic lipid droplet biology: getting to the root of fatty liver. Hepatology 62, 964–967 (2015).
  PubMed PubMed Central Google Scholar
• Cartwright, B. R. & Goodman, J. M. Seipin: from human disease to molecular mechanism. J. Lipid Res. 53, 1042–1055 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pawella, L. M. et al. Perilipin discerns chronic from acute hepatocellular steatosis. J. Hepatol. 60, 633–642 (2014).
  CAS PubMed Google Scholar
• Okumura, T. Role of lipid droplet proteins in liver steatosis. J. Physiol. Biochem. 67, 629–636 (2011).
  CAS PubMed Google Scholar
• Straub, B. K., Stoeffel, P., Heid, H., Zimbelmann, R. & Schirmacher, P. Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis. Hepatology 47, 1936–1946 (2008).
  CAS PubMed Google Scholar
• Fujii, H. et al. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning. J. Atheroscler. Thromb. 16, 893–901 (2009).
  CAS PubMed Google Scholar
• Carr, R. M. et al. Perilipin staining distinguishes between steatosis and nonalcoholic steatohepatitis in adults and children. Clin. Gastroenterol. Hepatol. 15, 145–147 (2017).
  PubMed Google Scholar
• Missaglia, S., Coleman, R. A., Mordente, A. & Tavian, D. Neutral lipid storage diseases as cellular model to study lipid droplet function. Cells 8, E187 (2019).
  PubMed Google Scholar
• Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131–1135 (2009).
  CAS PubMed PubMed Central Google Scholar
• Schulze, R. J., Drizyte, K., Casey, C. A. & McNiven, M. A. Hepatic lipophagy: new insights into autophagic catabolism of lipid droplets in the liver. Hepatol. Commun. 1, 359–369 (2017).
  PubMed PubMed Central Google Scholar
• Zechner, R., Madeo, F. & Kratky, D. Cytosolic lipolysis and lipophagy: two sides of the same coin. Nat. Rev. Mol. Cell Biol. 18, 671–684 (2017).
  CAS PubMed Google Scholar
• Zubiete-Franco, I. et al. Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis. J. Hepatol. 64, 409–418 (2016).
  CAS PubMed Google Scholar
• Tanaka, S. et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology 64, 1994–2014 (2016).
  CAS PubMed Google Scholar
• Schrader, M., Costello, J., Godinho, L. F. & Islinger, M. Peroxisome-mitochondria interplay and disease. J. Inherit. Metab. Dis. 38, 681–702 (2015).
  CAS PubMed Google Scholar
• Houten, S. M., Violante, S., Ventura, F. V. & Wanders, R. J. The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu. Rev. Physiol. 78, 23–44 (2016).
  CAS PubMed Google Scholar
• Sassa, T. & Kihara, A. Metabolism of very long-chain fatty acids: genes and pathophysiology. Biomol. Ther. 22, 83–92 (2014).
  CAS Google Scholar
• Laffel, L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15, 412–426 (1999).
  CAS PubMed Google Scholar
• Pawlak, M., Lefebvre, P. & Staels, B. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J. Hepatol. 62, 720–733 (2015).
  CAS PubMed Google Scholar
• Gibbons, G. F., Islam, K. & Pease, R. J. Mobilisation of triacylglycerol stores. Biochim. Biophys. Acta 1483, 37–57 (2000).
  CAS PubMed Google Scholar
• Kimmel, A. R. & Sztalryd, C. The perilipins: Major cytosolic lipid droplet-associated proteins and their roles in cellular lipid storage, mobilization, and systemic homeostasis. Annu. Rev. Nutr. 36, 471–509 (2016).
  CAS PubMed Google Scholar
• Sunny, N. E., Parks, E. J., Browning, J. D. & Burgess, S. C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 14, 804–810 (2011).
  CAS PubMed PubMed Central Google Scholar
• Petersen, K. F., Befroy, D. E., Dufour, S., Rothman, D. L. & Shulman, G. I. Assessment of hepatic mitochondrial oxidation and pyruvate cycling in NAFLD by (13)C magnetic resonance spectroscopy. Cell Metab. 24, 167–171 (2016).
  CAS PubMed PubMed Central Google Scholar
• Croci, I. et al. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Gut 62, 1625–1633 (2013).
  CAS PubMed Google Scholar
• Kotronen, A. et al. Liver fat and lipid oxidation in humans. Liver Int. 29, 1439–1446 (2009).
  CAS PubMed Google Scholar
• Bugianesi, E. et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48, 634–642 (2005).
  CAS PubMed Google Scholar
• Sanyal, A. J. et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183–1192 (2001).
  CAS PubMed Google Scholar
• Palmieri, V. O., Grattagliano, I., Portincasa, P. & Palasciano, G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J. Nutr. 136, 3022–3026 (2006).
  CAS PubMed Google Scholar
• Del Ben, M. et al. Serum cytokeratin-18 is associated with NOX2-generated oxidative stress in patients with nonalcoholic fatty liver. Int. J. Hepatol. 2014, 784985 (2014).
  PubMed PubMed Central Google Scholar
• Del Ben, M. et al. NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 14, 81 (2014).
  PubMed PubMed Central Google Scholar
• Peng, K. Y. et al. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. J. Lipid Res. 59, 1977–1986 (2018).
  CAS PubMed PubMed Central Google Scholar
• Koliaki, C. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 21, 739–746 (2015).
  CAS PubMed Google Scholar
• DeLany, J. P., Windhauser, M. M., Champagne, C. M. & Bray, G. A. Differential oxidation of individual dietary fatty acids in humans. Am. J. Clin. Nutr. 72, 905–911 (2000).
  CAS PubMed Google Scholar
• Jones, P. J., Pencharz, P. B. & Clandinin, M. T. Whole body oxidation of dietary fatty acids: implications for energy utilization. Am. J. Clin. Nutr. 42, 769–777 (1985).
  CAS PubMed Google Scholar
• Schmidt, D. E., Allred, J. B. & Kien, C. L. Fractional oxidation of chylomicron-derived oleate is greater than that of palmitate in healthy adults fed frequent small meals. J. Lipid Res. 40, 2322–2332 (1999).
  CAS PubMed Google Scholar
• Hodson, L., Rosqvist, F. & Parry, S. A. The influence of dietary fatty acids on liver fat content and metabolism. Proc. Nutr. Soc. https://doi.org/10.1017/S0029665119000569 (2019).
• Rosqvist, F. et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 63, 2356–2368 (2014).
  PubMed Google Scholar
• Gibbons, G. F., Wiggins, D., Brown, A. M. & Hebbachi, A. M. Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32, 59–64 (2004).
  CAS PubMed Google Scholar
• Lehner, R., Lian, J. & Quiroga, A. D. Lumenal lipid metabolism: implications for lipoprotein assembly. Arterioscler. Thromb. Vasc. Biol. 32, 1087–1093 (2012).
  CAS PubMed Google Scholar
• Gibbons, G. F., Bartlett, S. M., Sparks, C. E. & Sparks, J. D. Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem. J. 287, 749–753 (1992).
  CAS PubMed PubMed Central Google Scholar
• Ohsaki, Y., Cheng, J., Suzuki, M., Fujita, A. & Fujimoto, T. Lipid droplets are arrested in the ER membrane by tight binding of lipidated apolipoprotein B-100. J. Cell Sci. 121, 2415–2422 (2008).
  CAS PubMed Google Scholar
• Hossain, T., Riad, A., Siddiqi, S., Parthasarathy, S. & Siddiqi, S. A. Mature VLDL triggers the biogenesis of a distinct vesicle from the trans-Golgi network for its export to the plasma membrane. Biochem. J. 459, 47–58 (2014).
  CAS PubMed PubMed Central Google Scholar
• Tiwari, S. & Siddiqi, S. A. Intracellular trafficking and secretion of VLDL. Arterioscler. Thromb. Vasc. Biol. 32, 1079–1086 (2012).
  CAS PubMed PubMed Central Google Scholar
• Adiels, M. et al. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25, 1697–1703 (2005).
  CAS PubMed Google Scholar
• Fabbrini, E. et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134, 424–431 (2008).
  CAS PubMed Google Scholar
• Adiels, M., Olofsson, S. O., Taskinen, M. R. & Boren, J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28, 1225–1236 (2008).
  CAS PubMed Google Scholar
• Malmstrom, R. et al. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 47, 779–787 (1998).
  CAS PubMed Google Scholar
• Adiels, M. et al. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50, 2356–2365 (2007).
  CAS PubMed Google Scholar
• Adiels, M. et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49, 755–765 (2006).
  CAS PubMed Google Scholar
• Higuchi, N. et al. Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease. Exp. Ther. Med. 2, 1077–1081 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mahdessian, H. et al. TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content. Proc. Natl Acad. Sci. USA 111, 8913–8918 (2014).
  CAS PubMed Google Scholar
• Sliz, E. et al. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum. Mol. Genet. 27, 2214–2223 (2018).
  CAS PubMed PubMed Central Google Scholar
• Umpleby, A. M. et al. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets. Clin. Sci. 131, 2561–2573 (2017).
  CAS PubMed PubMed Central Google Scholar
• Parks, E. J., Krauss, R. M., Christiansen, M. P., Neese, R. A. & Hellerstein, M. K. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J. Clin. Invest. 104, 1087–1096 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gill, J. M. et al. Effects of dietary monounsaturated fatty acids on lipoprotein concentrations, compositions, and subfraction distributions and on VLDL apolipoprotein B kinetics: dose-dependent effects on LDL. Am. J. Clin. Nutr. 78, 47–56 (2003).
  CAS PubMed Google Scholar
• Hazlehurst, J. M., Woods, C., Marjot, T., Cobbold, J. F. & Tomlinson, J. W. Non-alcoholic fatty liver disease and diabetes. Metabolism 65, 1096–1108 (2016).
  CAS PubMed PubMed Central Google Scholar
• Green, C. J., Marjot, T., Tomlinson, J. W. & Hodson, L. Of mice and men: is there a future for metformin in the treatment of hepatic steatosis? Diabetes Obes. Metab. 21, 749–760 (2019).
  PubMed Google Scholar
• Cussons, A. J., Watts, G. F., Mori, T. A. & Stuckey, B. G. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J. Clin. Endocrinol. Metab. 94, 3842–3848 (2009).
  CAS PubMed Google Scholar
• de Castro, G. S. & Calder, P. C. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clin. Nutr. 37, 37–55 (2018).
  PubMed Google Scholar
• Musa-Veloso, K. et al. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutr. Rev. 76, 581–602 (2018).
  PubMed PubMed Central Google Scholar
• Tanaka, N. et al. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 42, 413–418 (2008).
  CAS PubMed Google Scholar
• Hodson, L. et al. Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. Eur J. Clin. Nutr. 71, 1251 (2017).
  CAS PubMed PubMed Central Google Scholar
• Kim, C. W. et al. Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation. Cell Metab. 26, 394–406 (2017).
  CAS PubMed PubMed Central Google Scholar
• Zhu, L. et al. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism 60, 1001–1011 (2011).
  CAS PubMed Google Scholar
• Greco, D. et al. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1281–G1287 (2008).
  CAS PubMed Google Scholar
• Zhou, J. et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 134, 556–567 (2008).
  CAS PubMed Google Scholar
• Li, Y. et al. CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway. J. Lipid Res. 60, 844–855 (2019).
  CAS PubMed PubMed Central Google Scholar
• Fernandez-Rojo, M. A. & Ramm, G. A. Caveolin-1 function in liver physiology and disease. Trends Mol. Med. 22, 889–904 (2016).
  CAS PubMed Google Scholar
• Patni, N. & Garg, A. Congenital generalized lipodystrophies-new insights into metabolic dysfunction. Nat. Rev. Endocrinol. 11, 522–534 (2015).
  CAS PubMed Google Scholar
• Wang, G., Bonkovsky, H. L., de Lemos, A. & Burczynski, F. J. Recent insights into the biological functions of liver fatty acid binding protein 1. J. Lipid Res. 56, 2238–2247 (2015).
  CAS PubMed PubMed Central Google Scholar
• Charlton, M. et al. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology 49, 1375–1384 (2009).
  CAS PubMed PubMed Central Google Scholar
• Westerbacka, J. et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56, 2759–2765 (2007).
  CAS PubMed Google Scholar
• Quiroga, A. D. & Lehner, R. Pharmacological intervention of liver triacylglycerol lipolysis: the good, the bad and the ugly. Biochem. Pharmacol. 155, 233–241 (2018).
  CAS PubMed Google Scholar
• Ruby, M. A. et al. Human carboxylesterase 2 reverses obesity-induced diacylglycerol accumulation and glucose intolerance. Cell Rep. 18, 636–646 (2017).
  CAS PubMed PubMed Central Google Scholar
• Lord, C. C. & Brown, J. M. Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling. Adipocyte 1, 123–131 (2012).
  CAS PubMed PubMed Central Google Scholar
• Carr, R. M. & Ahima, R. S. Pathophysiology of lipid droplet proteins in liver diseases. Exp. Cell Res. 340, 187–192 (2016).
  CAS PubMed Google Scholar
• Li, C. et al. Roles of acyl-CoA:diacylglycerol acyltransferases 1 and 2 in triacylglycerol synthesis and secretion in primary hepatocytes. Arterioscler. Thromb. Vasc. Biol. 35, 1080–1091 (2015).
  PubMed Google Scholar
• Goh, V. J. & Silver, D. L. The lipid droplet as a potential therapeutic target in NAFLD. Semin. Liver Dis. 33, 312–320 (2013).
  CAS PubMed Google Scholar
• Jump, D. B., Torres-Gonzalez, M. & Olson, L. K. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem. Pharmacol. 81, 649–660 (2011).
  CAS PubMed Google Scholar
• Harriman, G. et al. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc. Natl Acad. Sci. USA 113, E1796–E1805 (2016).
  CAS PubMed Google Scholar
• Lally, J. S. V. et al. Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma. Cell Metab. 29, 174–182 (2019).
  CAS PubMed Google Scholar
• Loomba, R. et al. GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease. Gastroenterology 155, 1463–1473 (2018).
  CAS PubMed PubMed Central Google Scholar
• Stiede, K. et al. Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: a randomized, double-blind, crossover study. Hepatology 66, 324–334 (2017).
  CAS PubMed PubMed Central Google Scholar
• McLaren, D. G. et al. DGAT2 inhibition alters aspects of triglyceride metabolism in rodents but not in non-human primates. Cell Metab. 27, 1236–1248 (2018).
  CAS PubMed Google Scholar